Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
Browse
Publications
Preprints
About
About UCL Open: Env.
Aims and Scope
Editorial Board
Indexing
APCs
How to cite
Publishing policies
Editorial policy
Peer review policy
Equality, Diversity & Inclusion
About UCL Press
Contact us
For authors
Information for authors
How it works
Benefits of publishing with us
Submit
How to submit
Preparing your manuscript
Article types
Open Data
ORCID
APCs
Contributor agreement
For reviewers
Information for reviewers
Review process
How to peer review
Peer review policy
My ScienceOpen
Sign in
Register
Dashboard
Search
3
views
0
references
Top references
cited by
0
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,579
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Imipenem‐Cilastatin‐Relebactam for injection [package insert]
Author(s):
Merck
Publication date:
2019
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Stroke: Karger Topic Article Package
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,579
Activity of imipenem-relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic beta-lactam-resistant mutants
Authors:
PA Fraile-Ribot
,
L ZAMORANO
,
R ORELLANA
RESTORE-IMI 1: A Multicenter, Randomized, Doubleblind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients with Imipenem-nonsusceptible Bacterial Infections
Authors:
J. Motsch
,
CUM De Oliveira
,
V Stus
Relebactam increases susceptibility of Enterobacterales and Pseudomonas aeruginosa to imipenem in both imipenem-susceptible and imipenem-nonsusceptible gram-negative bacteria- global SMART 2017–2019
Authors:
DW HILBERT
,
CA DeRyke
,
P Moise
See all similar